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Abstract. 
 
To determine whether the p75 neurotrophin 
receptor (p75NTR) plays a role in naturally occurring 
neuronal death, we examined neonatal sympathetic 
neurons that express both the TrkA tyrosine kinase re-
ceptor and p75NTR. When sympathetic neuron sur-
vival is maintained with low quantities of NGF or KCl, 
the neurotrophin brain-derived neurotrophic factor 
(BDNF), which does not activate Trk receptors on 
sympathetic neurons, causes neuronal apoptosis and 
increased phosphorylation of c-jun. Function-blocking 
antibody studies indicate that this apoptosis is due to 
BDNF-mediated activation of p75NTR. To determine 
the physiological relevance of these culture findings, we 
 
examined sympathetic neurons in BDNF
 
2
 
/
 
2
 
 and 
p75NTR
 
2
 
/
 
2
 
 mice. In BDNF
 
2
 
/
 
2
 
 mice, sympathetic 
neuron number is increased relative to BDNF
 
1
 
/
 
1
 
 lit-
termates, and in p75NTR
 
2
 
/
 
2
 
 mice, the normal period 
of sympathetic neuron death does not occur, with neu-
ronal attrition occurring later in life. This deficit in apop-
tosis is intrinsic to sympathetic neurons, since cultured 
p75NTR
 
2
 
/
 
2
 
 neurons die more slowly than do their 
wild-type counterparts. Together, these data indicate 
that p75NTR can signal to mediate apoptosis, and that 
this mechanism is essential for naturally occurring sym-
pathetic neuron death.
 
T
 
he 
 
p75 neurotrophin receptor (p75NTR)
 
1
 
 (Johnson
et al., 1986; Radeke et al., 1987) is the first member
discovered of a family of receptors, including fas
and TNFR1, which have been shown to mediate cellular
differentiation and apoptosis (for review see Chao, 1994).
p75NTR can interact with all of the mammalian members
of the neurotrophin family (for review see Levi-Montal-
cini, 1987; Barde, 1989; Snider, 1994), NGF, brain-derived
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and
neurotrophin-4 (NT-4), with approximately equivalent af-
finities (Rodriguez-Tebar et al., 1990, 1992). In contrast,
the other family of neurotrophin receptors, the Trk ty-
rosine kinases (for review see Barbacid, 1994), display a
specificity for binding individual neurotrophins: NGF and
NT-3 for TrkA (Cordon-Cardo et al., 1991; Klein et al.,
1991; Kaplan et al., 1991
 
a
 
,
 
b
 
); BDNF and NT-4 for TrkB
(Soppet et al., 1991); and NT-3 for TrkC (Lamballe et al.,
1993; Tsoulfas et al., 1993). Whereas much is known about
the signaling and biological roles of the Trks in neurons in
vivo and in vitro, the functional role of p75NTR in neu-
rons has remained elusive.
p75NTR was originally reported to function as a posi-
tive regulator of TrkA activity in a number of neural cell
lines (Benedetti et al., 1993; Ip et al., 1993; Barker and
Shooter, 1994; Verdi et al., 1994). The initial report of the
p75NTR knockout mouse apparently supported this hy-
pothesis, since these mice exhibited a loss of nociceptive
and thermosensitive sensory neurons (Lee et al., 1992),
phenotypes observed in a more severe form in the NGF
(Crowley et al., 1994) and TrkA knockout mice (Smeyne
et al., 1994). However, other defects have been observed
in the p75NTR knockout mice that are more difficult to
explain on the basis of p75NTR positively regulating
TrkA; defects such as a selective loss of sympathetic inner-
vation without an apparent loss of sympathetic neurons
(Lee et al., 1992, 1994), and an increase in the number of
basal forebrain cholinergic neurons (van der Zee et al.,
1996) with a coincident increase in cholinergic innervation
of the hippocampus (Yeo et al., 1997).
More recent evidence indicates that, in addition to mod-
ulating Trk function, p75NTR signals on its own. Specifi-
cally, in neural cell lines and glial cells, neurotrophin bind-
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ing to p75NTR stimulates the generation of ceramide
(Dobrowsky et al., 1994, 1995; Casaccia-Bonnefil et al.,
1996), activation of nuclear factor (NF)-kB and transloca-
tion of this protein to the nucleus (Carter et al., 1996), and
enhancement of jun kinase (JNK) activity (Casaccia-Bon-
nefil et al., 1996). Such signaling likely mediates the effects
of NGF on Schwann cells, which do not express TrkA, and
which respond to NGF with migration (Anton et al., 1994).
Similarly, NGF-mediated activation of p75NTR signaling
in cultured oligodendrocytes leads to apoptosis (Casaccia-
Bonnefil et al., 1996).
In spite of this progress in our understanding of
p75NTR function in cell lines and glial cells, the functional
role of this receptor in neurons remains elusive. However,
a number of recent studies indicate that p75NTR may play
a role in regulating neuronal survival. First, Rabizadeh et al.
(1993) reported that p75NTR decreased survival of a neu-
ral tumor cell line in a ligand-independent fashion,
whereas Barrett and Bartlett (1994) reported that func-
tional ablation of p75NTR enhanced survival of cultured
postnatal sensory neurons. However, neither of these re-
ports determined whether p75NTR mediated these re-
sponses on its own, or by modulating Trk activity. Second,
addition of NGF in vivo to neurons of the developing
chick isthmo-optic nucleus, which express p75NTR but not
TrkA, led to cell death by an undefined mechanism (von
Bartheld et al., 1994). Third, addition of anti-NGF anti-
bodies to the developing chick retina led to decreased
death of cells that express p75NTR but not TrkA (Frade
et al., 1996). In this latter study, unlike that with the chick
isthmo-optic nucleus neurons, addition of excess NGF had
no effect. Finally, expression of the intracellular domain of
p75NTR as a transgene in mouse neurons resulted in apop-
tosis of selected populations of peripheral and central neu-
rons, indicating the cell death–inducing potential of p75NTR
(Majdan et al., 1997). However, whereas these studies im-
plicate p75NTR in neuronal apoptosis, the mechanism
whereby this occurs, and its physiological roles remain un-
clear.
We have addressed these issues by investigating the role
of p75NTR in postnatal rat sympathetic neurons during
the developmental period of naturally occurring cell
death. These neurons express relatively high levels of
TrkA and p75NTR, low levels of functional TrkC (Bel-
liveau et al., 1997), and have an absolute requirement for
NGF for survival (Levi-Montalcini et al., 1960
 
a
 
,
 
b
 
). We
have recently demonstrated that TrkA activation is neces-
sary for sympathetic neuron survival, and that NGF and
NT-3 are both capable of eliciting TrkA activation on
these neurons (Belliveau et al., 1997). However, surpris-
ingly, whereas NT-3 is as effective as NGF in mediating
neuritogenesis, it is two- to fourfold less effective at medi-
ating neuronal survival at equivalent levels of TrkA acti-
vation. Since NT-3 is much less efficient at activating TrkA
than NGF (Cordon-Cardo et al., 1991; Belliveau et al.,
1997), and approximately equivalent at binding p75NTR
(Rodriguez-Tebar et al., 1992), we hypothesized that this
difference in survival was a consequence of a balance be-
tween differential activation of TrkA versus p75NTR on
sympathetic neurons. In studies reported here, we have
tested this hypothesis. Our data indicate that p75NTR can
signal to mediate neuronal apoptosis, and that this mecha-
 
nism is essential for naturally occurring sympathetic neu-
ron cell death.
 
Materials and Methods
 
Primary Neuronal Cultures
 
Mass cultures of pure sympathetic neurons from the superior cervical gan-
glion (SCG) of postnatal day 1 rats were prepared as previously described
(Ma et al., 1992). Neurons were plated on rat tail collagen-coated tissue
culture dishes; 4-well plates (Falcon Plastics, Cockeysville, MD) for mor-
phological measurements, 6-well plates for biochemistry, and 48-well
plates for 3-[4,5-dimethylthio-zol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) assays. Low density SCG cultures were used for all of the survival
assays; for the MTT assays, neurons were used at a density of 1,500–2,000
neurons per well of a 48-well plate. Similar neuronal densities were used
for the TUNEL assays, but the neurons were plated on poly-
 
d
 
-lysine and
laminin. For biochemistry, 
 
z
 
100,000 neurons were plated per well of a
6-well dish. For all experiments, neurons were initially cultured for 5 d in
the presence of 10 or 50 ng/ml NGF. At the end of this 5-d selection, neu-
rons were washed several times in neurotrophin-free media before addi-
tion of the new neurotrophin- or KCl-containing media.
NGF for these experiments was purified from mouse salivary glands
(Cedarlane Labs. Ltd., Hornby, Ontario, Canada). Purified recombinant
NT-4 was obtained from Genentech (South San Francisco, CA). Two
sources of recombinant human BDNF (Amgen, Thousand Oaks, CA; Pre-
proTech, Inc., Rocky Hill, NJ) were used for these experiments to ensure
that the results were not because of unsuspected toxicity associated with
one of the sources. Both preparations of BDNF caused TrkB autophos-
phorylation on TrkB-expressing NIH-3T3 cells (data not shown). More-
over, these sources of BDNF have been used on primary cultures of corti-
cal progenitor cells, cortical neurons, and hippocampal neurons, with no
evidence of cytotoxicity (data not shown). The p75NTR function-blocking
antibody REX (Weskamp and Reichardt, 1991) (the gift of L. Reichardt,
University of California, San Francisco, CA) is directed against the extra-
cellular domain of the receptor, and was used as an antiserum at a dilution
of 1:150.
Mouse sympathetic neurons were cultured by a modification of the
method used for rat neurons. Specifically, neurons were dissected and trit-
urated as for rat neurons (Ma et al., 1992), except that neurons were disso-
ciated in the presence of media instead of saline solution. Neurons were
then plated on collagen-coated culture dishes in Ultraculture media (Bio-
Whittaker, Inc.) containing 2 mM glutamine, 100 U/ml penicillin, 100 
 
m
 
g/ml
streptomycin, 3% FBS (Life Technologies, Inc., Gaithersburg, MD), and
50 ng/ml NGF. 3 d after plating, the neurons were fed with the same media
containing 0.5% cytosine arabinoside.
 
TUNEL and Survival Assays
 
TUNEL assays were performed as previously described (Slack et al.,
1996). For survival assays, analysis was performed 48 h later using nonra-
dioactive cell proliferation (MTT) assays (Celltitre 96; Promega Corp.,
Madison, WI). 20 
 
m
 
l of the MTT reagent as added to each well and left for
90 min, followed by the addition of 200 
 
m
 
l of solubilization solution to lyse
the cells. Each condition was repeated in triplicate. In each assay, baseline
(0% survival) was considered to be 0 ng/ml NGF, and 10 ng/ml NGF was
considered to be 100% survival. All other conditions were related to these
values. For the REX experiment, neurons were washed with neurotro-
phin-free media for 3 h, and were then preincubated in media 
 
1
 
 KCl 
 
1
 
REX for 2 h, at which point the BDNF was added for 48 h.
Survival assays for p75NTR
 
2
 
/
 
2
 
 versus p75NTR
 
1
 
/
 
1
 
 neurons were
performed by counting randomly selected fields of cultured neurons. Spe-
cifically, after 5 d in culture, neurons were washed with four changes of
neurotrophin-free media for a total of 2.5 h, and then maintained in media
with no added neurotrophins. The number of phase-bright neurons with
neurites in randomly selected, 5.3-mm
 
2
 
 fields was counted immediately af-
ter the switch to NGF-free media, and was recounted in the same fields at
24-h intervals for 5 d. In each individual experiment, each condition was
repeated in triplicate. As controls for the p75NTR
 
2
 
/
 
2
 
 neurons, neurons
were cultured from mice of either C129 or CD1 backgrounds. Results for
neurons from either background were similar, and were therefore com-
bined. In three of the five experiments analyzed, p75NTR
 
2
 
/
 
2
 
 and
p75NTR
 
1
 
/
 
1
 
 neurons were cultured at the same time in the same 48-well
plates to eliminate potential variability. 
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Immunoprecipitations and Western Blot Analysis
 
For Trk assays, sympathetic neurons were lysed in TBS lysis buffer (Knu-
sel et al., 1994) containing 137 mM NaCl, 20 mM Tris, pH 8.0, 1% (vol/
vol) NP-40, 10% (vol/vol) glycerol, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin, 0.2
 
m
 
g/ml leupeptin, 5 mM phenanthroline, and 1.5 mM sodium vanadate. 1
ml of cold TBS was added to one or two wells of a six-well dish, and cells
were collected, resuspended in 100 
 
m
 
l lysis buffer, and rocked for 20 min
at 4
 
8
 
C. Each sample was vortexed for 10 s, and cleared by centrifugation.
The lysates were normalized for protein concentration using a BCA Pro-
tein Assay Reagent (Pierce Chemical Co., Rockford, Ill). Total Trk pro-
tein was immunoprecipitated using 3 
 
m
 
l of anti–panTrk 203 (the gift of D.
Kaplan, Montreal Neurological Institute, Montreal, Canada), and TrkA
using 2 
 
m
 
l of anti–TrkA RTA (the gift of L. Reichardt). The immunopre-
cipitates were collected with protein A–Sepharose (Pharmacia Biotechnol-
ogy Inc., Piscataway, NJ) for 1.5 h at 4
 
8
 
C followed by centrifugation.
For Western blot analysis, precipitates were washed three times with
cold lysis buffer, boiled in sample buffer (2% SDS, 100 mM dithiothreitol,
10% glycerol, and 0.05% bromophenol blue) for 5 min, and electropho-
resed on 8% SDS–polyacrylamide minigels. After electrophoresis, pro-
teins were transferred to 0.2 
 
m
 
m nitrocellulose for 1 h at 0.5 Amps, and the
membrane washed twice for 10 min in TBS. For all antibodies except anti-
phosphotyrosine, for which membranes were blocked in 2% BSA (Sigma
Chemical Co.), membranes were blocked in 5% nonfat dry milk, in TBS
for 2.5 h. Membranes were then washed twice for 10 min in TBS, and the
primary antibodies were used overnight at 4
 
8
 
C, at a dilution of 1:5,000 for
anti-phosphotyrosine 4G10 (Upstate Biotechnology Inc., Lake Placid, NY),
and 1:1,000 or 1:2,000 for anti–panTrk 203. Secondary antibodies were in-
cubated for 1.5 h at room temperature, and were used at a dilution of
1:10,000 or 1:20,000 for a goat anti–mouse HRP antibody (Boehringer Mann-
heim Corp., Indianapolis, IN; used for anti-phosphotyrosine), 1:10,000 for a
goat anti–rabbit HRP antibody (Boehringer Mannheim Corp.; used for
anti-TrkA), and 1:2,000 for protein A–HRP (Sigma Chemical Co.; used for
anti-panTrk). Detection was carried out using enhanced chemilumines-
cence (Amersham Corp., Arlington Heights, IL) and XAR x-ray film (East-
man Kodak, Rochester, NY). Results were quantitated by image analysis.
For biochemical analysis of c-jun, the collected cells were incubated 20
min at 4
 
8
 
C in lysis buffer plus 0.5% SDS. After protein determination, 50 
 
m
 
g
of protein was boiled in sample buffer, and separated on a 10% acryla-
mide gel, transferred, and then Western blotted with antibodies specific to
c-jun at a 1:1,000 dilution, using the protocols described above. For the
c-jun experiments, two different antibodies were used, anti–c-jun J3192
(Transduction Labs., Lexington, KY), and anti–c-jun SC-822 (Santa Cruz
Biotech, Santa Cruz, CA). Both antibodies produced similar results on
Western blots.
 
Analysis of BDNF
 
2
 
/
 
2
 
 and p75NTR
 
2
 
/
 
2
 
 Mice
 
Mice heterozygous for a targeted mutation in the BDNF gene (Ernfors et al.,
1994) and homozygous for a targeted mutation in the p75NTR gene (Lee
et al., 1992) were obtained from Jackson Labs. (Bar Harbor, ME). The
BDNF
 
2
 
/
 
2
 
 mice were maintained in a C129/BalbC background. The
p75NTR
 
2
 
/
 
2
 
 mice were originally generated in a C129/BalbC background
(Lee et al., 1992), were crossed back into a C129 background before pur-
chase from Jackson Labs., and were then maintained as homozygotes.
Progeny from BDNF heterozygote crosses were screened for the mutant
allele(s) using PCR. To amplify the wild-type allele, two PCR oligonucle-
otide primers were used (5
 
9
 
-ATGAAAGAAGTAAACGTCCAC-3
 
9
 
 and
5
 
9
 
-CCAGCAGAAAGAGTAGAGGAG-3
 
9
 
) to generate a 275-nucle-
otide product. To amplify the mutant allele, two oligonucleotide primers
specific to this allele were used (5
 
9
 
-GGGAACTTCCTGACTAGGGG-3
 
9
 
and 5
 
9
 
-ATGAAAGAAGTAAACGTCCAC-3
 
9
 
) to generate a 340-nucle-
otide product.
For morphometric analysis, the SCG were removed and immersion
fixed in 4% paraformaldehyde in phosphate buffer (PB) from 1 h to over-
night at 4
 
8
 
C. Ganglia were cryoprotected in graded sucrose solutions, 7-
 
m
 
m-
thick sections were serially cut on a cryostat, and every section was col-
lected and thaw mounted onto chrom-alum–subbed slides. Slides were
stained with cresyl violet and morphometric analyses were performed us-
ing a computer-based image analysis system (Biocom, Paris, France).
Neuronal sizes were determined by randomly measuring the cross-sec-
tional area of neurons containing a distinct nucleolus. Neuronal numbers
were determined by counting all neuronal profiles with nucleoli on every
third section for the BDNF
 
2
 
/
 
2
 
 mice, and every fourth section for the
p75NTR
 
2
 
/
 
2
 
 mice, as per Coggeshall (1984). This sampling frequency (every
21 and 28 
 
m
 
m, respectively) ensures that neurons are not double counted,
since the average neuronal diameter does not exceed 21 
 
m
 
m in any of the
groups examined (see Results section). This method does not correct for
split nucleoli. As a second approach, neuronal numbers were estimated
using measurements of total SCG volume and neuronal density. To deter-
mine ganglion volume, the combined cross-sectional area of every third
(BDNF
 
2
 
/
 
2
 
) or every fourth (p75NTR
 
2
 
/
 
2
 
) serial section was measured.
This cross-sectional area was normalized for total number of sections, and
multiplied by 7 
 
m
 
m (the section thickness) to obtain the total SCG vol-
ume. To measure mean neuronal density, the number of neurons in a ran-
domly applied sampling window of 175 
 
m
 
m 
 
3
 
 175 
 
m
 
m was counted. For
the BDNF
 
2
 
/
 
2
 
 and BDNF
 
1
 
/
 
1
 
 animals, the sampling window was 182 
 
m
 
m
 
3
 
 182 
 
m
 
m, and the mean neuronal densities were then normalized to a 175
 
m
 
m 
 
3
 
 175 
 
m
 
m sampling window (a normalization factor of 1.08). To esti-
mate neuronal number from these two parameters, we calculated SCG
volume 
 
x
 
 (mean neuron number/214,375 
 
m
 
m
 
3
 
), where 214,375 
 
m
 
m
 
3
 
 is the
sampling window volume (175 
 
m
 
m 
 
3
 
 175 
 
m
 
m 
 
3
 
 7 
 
m
 
m). This calculation
was performed either (
 
a
 
) on an individual ganglion basis or (
 
b
 
) using the
mean volume and the mean pooled neuronal density obtained from at
least three individual animals. Since the numbers obtained were similar in
both cases, only the latter calculation is presented in the results. Statistical
results were expressed as the mean 
 
6
 
 the standard error of the mean and
were tested for significance by a one-tailed Student’s 
 
t
 
 test.
 
Results
 
Differential Neurotrophin Binding to TrkA Versus 
p75NTR Correlates with Sympathetic Neuron Survival 
Versus Death
 
To determine whether differences in neurotrophin binding
to TrkA versus p75NTR regulate neuronal survival, as
suggested by our previous results (Belliveau et al., 1997),
we compared NGF and NT-4, both of which bind only
TrkA and p75NTR on sympathetic neurons. For these
studies, postnatal day 1 sympathetic neurons were first se-
lected for 5 d in 10 ng/ml NGF, washed free of NGF, ex-
posed to varying concentrations of NGF and NT-4, and
then analyzed for TrkA activation relative to neuronal
survival. For the biochemical measurements, neurons
were exposed to these two neurotrophins for 10 min, cell
lysates were immunoprecipitated with anti-TrkA (RTA;
Clary et al., 1994), and the precipitated TrkA was analyzed
for autophosphorylation on Western blots using anti-phos-
photyrosine. This biochemical analysis revealed that NT-4
was similar to NT-3 in its ability to activate TrkA on sym-
pathetic neurons (Fig. 1 
 
A
 
; data not shown). NT-4 was,
however, 
 
z
 
10- to 20-fold less efficient at activating TrkA
than NGF (Fig. 1 
 
A
 
), with 2.5 ng/ml NGF being equivalent
to 
 
z
 
50 ng/ml NT-4.
To compare the survival promoting activity of these two
TrkA/p75 ligands, we then cultured the NGF-dependent
neurons in 0–10 ng/ml NGF or 10–100 ng/ml NT-4 for 2 d
(Fig. 2 
 
A
 
). MTT assays revealed that 2.5 and 5 ng/ml NGF
supported 
 
z
 
55% and 85% sympathetic neuron survival,
respectively. In contrast, 50 and 100 ng/ml NT-4, which
lead to approximately equal levels of TrkA activation (Fig.
1 
 
A
 
) supported only 
 
z
 
10% and 25% neuronal survival, re-
spectively. Thus, when compared to NGF, NT-4 was 
 
z
 
40-
fold less potent at mediating neuronal survival, and 
 
z
 
5-
fold less efficient when normalized for similar levels of
TrkA autophosphorylation (Figs. 1 
 
A
 
 and 2 
 
A
 
). Since NT-4
binds far less well to TrkA than NGF, and more efficiently
to p75NTR (Rodriguez-Tebar et al., 1992), we hypothe-
sized that, at low levels of TrkA activity, coincident activa-
tion of p75NTR might “override” the TrkA survival signal.
To test this hypothesis, we cultured sympathetic neurons 
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in limiting amounts of NGF with and without the presence
of a p75NTR ligand, BDNF. We chose the neurotrophin
BDNF, which binds to p75NTR (Rodriguez-Tebar et al.,
1990), since BDNF does not bind to the two Trk receptors
present on neonatal sympathetic neurons, TrkA and TrkC
(Lamballe et al., 1993). We first confirmed biochemically
that BDNF is selective for p75NTR on these neurons, by
examining short- and long-term total Trk autophosphory-
lation. For the short-term experiments, neonatal sympa-
thetic neurons were grown for 5 d in 10 ng/ml NGF, and
were then exposed to BDNF for 10 min. Cellular lysates
were immunoprecipitated with an antibody that recog-
nizes all members of the Trk receptor family (anti–panTrk
203; Hempstead et al., 1992), and the precipitated Trk ex-
amined for BDNF-induced tyrosine autophosphorylation
by probing Western blots with anti-phosphotyrosine. These
studies demonstrated that concentrations of BDNF rang-
ing from 30 to 100 ng/ml (Fig. 1 
 
B
 
) did not lead to short-
term activation of Trk receptors on sympathetic neurons.
For the long-term experiments, sympathetic neurons
were selected for 5 d in 10 ng/ml NGF, and then were
switched for 2 d either to 10 ng/ml NGF plus 100 ng/ml
BDNF, or to 10 ng/ml NGF plus 100 ng/ml NGF; 10 ng/ml
NGF was required in these experiments to support neu-
ronal survival. 2 d later, the Trk proteins were analyzed for
BDNF or NGF-induced tyrosine phosphorylation (Fig. 1 C).
These studies revealed that, as previously reported (Bel-
liveau et al., 1997), 110 ng/ml NGF led to higher levels of
long-term Trk autophosphorylation than did 10 ng/ml NGF.
However, Trk autophosphorylation in 10 ng/ml NGF plus
100 ng/ml BDNF was unchanged relative to 10 ng/ml NGF
alone. Thus, as predicted, BDNF does not activate either
TrkA or TrkC on sympathetic neurons, and represents a
p75NTR-selective ligand for these experiments.
To test the hypothesis that at low levels of TrkA activ-
ity, coincident activation of p75NTR could override the
TrkA survival signal, we cultured sympathetic neurons in
50 ng/ml NGF for 5 d, and then switched them into 2.5 ng/ml
Figure 1. (A) NT-4 activates TrkA on sympa-
thetic neurons. Sympathetic neurons were se-
lected in 10 ng/ml NGF for 5 d, washed free of
neurotrophin, and then exposed to various con-
centrations of NGF (from 2.5 to 10 ng/ml) or NT-4
(50 and 100 ng/ml) for 10 min. Cellular lysates
were immunoprecipitated with an antibody specific
to TrkA, and probed first with anti-phosphoty-
rosine (anti-ptyr) to visualize TrkA autophosphor-
ylation, and then reprobed with anti-panTrk to
monitor total TrkA levels (anti-pantrk). All sam-
ples were normalized for equal amounts of pro-
tein. (B and C) BDNF does not activate Trk on
sympathetic neurons. (B) To examine short-term
Trk autophosphorylation, sympathetic neurons
were washed free of NGF and exposed to 2.5, 5,
or 10 ng/ml NGF or to 30 or 100 ng/ml BDNF for
10 min. Total Trk protein was immunoprecipi-
tated with anti-panTrk, and Trk autophosphory-
lation analyzed by blotting with anti-phosphoty-
rosine (anti-ptyr). In the bottom panel, the same
blot was reprobed with panTrk antibody 203
(anti-pantrk) to ensure that similar amounts of
total Trk protein were present in all lanes. (C) To
examine long-term Trk autophosphorylation,
sympathetic neurons were selected in 10 ng/ml
NGF, and then switched to 10 ng/ml NGF (10
NGF), 110 ng/ml NGF (110 NGF), or 10 ng/ml
NGF 1 100 ng/ml BDNF (10 NGF 1 100 BDNF).
Analysis of Trk autophosphorylation was per-
formed as in B. In all cases, samples were nor-
malized for equal amounts of protein, and blots
were reprobed for total Trk protein levels. (D)
KCl treatment does not lead to Trk activation on
sympathetic neurons. Sympathetic neurons were
washed free of neurotrophin and switched to 10
ng/ml NGF for 10 min, or to 25 or 50 mM KCl for
10 min or 24 h. Trk autophosphorylation was an-
alyzed as in B. (E and F) BDNF-mediated activa-
tion of p75 leads to increased phosphorylation of
c-jun. Sympathetic neurons were selected in 50 ng/ml NGF, washed free of neurotrophin, and then switched to 10 ng/ml NGF, or 12.5 or 25
mM KCl plus or minus BDNF. 18 h later, cellular lysates were analyzed for c-jun on Western blots. (E) As previously reported (Ham et
al., 1995), the size of c-jun increases in response to NGF withdrawal, a shift indicative of increased phosphorylation. 200 ng/ml BDNF
caused a similar size shift in the presence of 12.5 mM KCl. (F) This size shift was specific to BDNF and not to KCl, as shown here with 25
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NGF for 2 d, with or without BDNF. 50 ng/ml NGF was
used for the initial selection since we have previously dem-
onstrated (Belliveau et al., 1997) that p75NTR levels are
significantly higher in sympathetic neurons cultured in 50
ng/ml NGF versus 10 ng/ml NGF, whereas TrkA levels re-
main constant. 2.5 ng/ml NGF was chosen for the survival
assay since this concentration of NGF is limiting for TrkA
activation and neuronal survival under our assay condi-
tions (Fig. 2 A). MTT assays demonstrated that 2.5 ng/ml
NGF alone mediated survival of 50–55% of sympathetic
neurons, and that the addition of 100 or 200 ng/ml BDNF
reduced this survival by 43 and 58%, respectively (Fig. 2 B).
In contrast, BDNF had less of an effect when TrkA activa-
tion was increased; addition of 100 ng/ml BDNF in the
presence of 5 ng/ml NGF reduced survival by 25% (Fig. 2 C),
and addition of BDNF to 10 ng/ml NGF (which supports
100% survival) had no effect (Fig. 2 C). Thus, BDNF re-
duces TrkA-mediated neuronal survival, but only when
the survival signal is suboptimal.
BDNF-mediated Activation of p75NTR Causes 
Sympathetic Neuron Apoptosis in the Absence of
TrkA Activation
One explanation for these data is that BDNF causes acti-
vation of p75NTR, and that a p75NTR-mediated apop-
totic signaling cascade can override survival signals medi-
ated by low levels of TrkA activation. An alternative
explanation is that BDNF competes with low levels of
NGF for binding to p75NTR, thereby affecting NGF bind-
ing to TrkA (Barker and Shooter, 1994). To differentiate
these two possibilities, we performed survival assays using
KCl instead of NGF to maintain sympathetic neuron sur-
vival. We first confirmed, as previously reported (Franklin
et al., 1995), that KCl maintained sympathetic neuron sur-
vival without activating Trk by measuring Trk autophos-
phorylation in neurons exposed to KCl for 10 min or 24 h
in the absence of neurotrophin (Fig. 1 D). Specifically, af-
ter an initial selection for 5 d in NGF, neurons were
washed free of NGF, and then were exposed to 25 or 50 mM
KCl for 10 min or 24 h. Cellular lysates were immunopre-
cipitated with anti-panTrk, and the precipitates were ana-
lyzed by Western blot analysis with anti-phosphotyrosine
(Fig. 1 D). These experiments confirmed that, as previ-
ously reported (Franklin et al., 1995), KCl did not lead to
an increase in autophosphorylation of Trk either in the
short or long term.
We then performed survival assays with KCl as we had
done for NGF and BDNF; sympathetic neurons selected
in 50 ng/ml NGF for 5 d were switched to KCl with or
without BDNF for 2 d. These assays were performed un-
der two conditions. In one case, we used 25 mM KCl,
which mediates maximal sympathetic neuron survival
(130% relative to 10 ng/ml NGF); and in the second, we
used 12.5 mM KCl, which is suboptimal, mediating z80–
85% survival (Fig. 2 D). MTT assays revealed that the ad-
dition of 100 ng/ml BDNF to 12.5 or 25 mM KCl decreased
neuronal survival significantly in both cases (Fig. 2 D). To
determine the concentration range of this BDNF-medi-
ated killing, we performed similar experiments using 12.5
mM KCl with the addition of 30–200 ng/ml BDNF. MTT
assays revealed a concentration-dependent decrease in neu-
Figure 2. (A) NT-4 is fivefold less efficient than NGF at support-
ing sympathetic neuron survival at equivalent levels of TrkA au-
tophosphorylation. A comparison of sympathetic neuron survival
in response to 2.5–10 ng/ml NGF versus 10–100 ng/ml NT-4, as
monitored using MTT assays that measure mitochondrial func-
tion and cell survival. Neonatal sympathetic neurons were cul-
tured in 10 ng/ml NGF for 5 d in 48-well dishes, washed free of
neurotrophin-containing medium, and then incubated for 2 d in
various concentrations of NGF or NT-4, as indicated on the
x-axis. Each point represents the values pooled from three inde-
pendent sets of survival assays, each of which was performed in
quadruplicate. In these assays, absolute values are normalized so
that the value obtained without neurotrophin is 0% survival,
whereas that obtained with 10 ng/ml NGF is considered 100%
survival. Error bars represent the standard error. (B–D) BDNF
decreases sympathetic neuron survival in the presence of limiting
quantities of NGF (B and C) or KCl (D). Neurons were selected
in 50 ng/ml NGF for 5 d, and then switched to 2.5 ng/ml NGF, 5
ng/ml NGF, 10 ng/ml NGF, 12.5 mM KCl, or 25 mM KCL, with
or without 100 or 200 ng/ml BDNF for 2 d. Survival was moni-
tored by MTT assays. Results are expressed relative to those ob-
tained with 10 ng/ml NGF, and represent the mean 6 standard
error. B and D include the combined data from three indepen-
dent experiments performed in triplicate. C represents the data
from one representative experiment performed in quadruplicate
(**P , 0.05, ***P , 0.005 relative to NGF [B and C] or KCl [D]
alone). (E) BDNF decreases sympathetic neuron survival in a
concentration-dependent fashion. Neurons were selected in 50
ng/ml NGF for 5 d, and then switched to 12.5 mM KCl with or
without concentrations of BDNF ranging from 30 to 200 ng/ml
for 2 d. Survival was monitored by MTT assays. Results are nor-
malized relative to those obtained with 12.5 mM KCl alone, and
represent the mean 6 standard error from the combined data of
four independent experiments (***P , 0.005 relative to 12.5 mM
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ronal survival commencing at 30 ng/ml BDNF (Fig. 2 E).
Thus, BDNF was sufficient to override survival signals me-
diated by KCl in a concentration-dependent fashion.
To demonstrate that the lack of neuronal survival de-
tected using MTT assays corresponded to neuronal apop-
tosis, we monitored the neurons morphologically, and by
TUNEL assays. Sympathetic neurons were first selected in
50 ng/ml NGF, were washed free of neurotrophin, and
then were switched to 12.5 or 25 mM KCl with or without
BDNF. As controls, neurons were switched to 50 ng/ml
NGF or were maintained without NGF. 18 h after the switch,
neurons maintained in 50 ng/ml NGF or 12.5 mM KCl ex-
hibited no TUNEL-positive nuclei, whereas neurons with-
drawn from NGF or maintained in 12.5 mM KCl 1 100 ng/ml
BDNF showed many TUNEL-positive nuclei (Fig. 3, A–D).
Similar results were obtained with neurons maintained in
25 mM KCl (data not shown). By 48 h, morphological ex-
amination revealed that all neurons maintained in 50 ng/ml
NGF were alive (Fig. 3 E), while in 12.5 mM KCl, many
neurons were alive, but some were also showing morpho-
logical signs of cell death (Fig. 3 F), consistent with the
MTT survival assays (Fig. 2 D). In contrast, no neurons
were apparently alive after 48 h of culture in 0 NGF (Fig. 3
G) or in 12.5 mM KCl plus 100 ng/ml BDNF (Fig. 3 H).
We also performed similar TUNEL assays on sympa-
thetic neurons maintained in suboptimal concentrations of
NGF and coincidentally exposed to BDNF. Specifically,
sympathetic neurons were cultured for 5 d in 50 ng/ml
NGF, and switched to 5 ng/ml NGF plus or minus 100 ng/ml
BDNF. TUNEL labeling was performed 24 h after this
switch; this analysis demonstrated a statistically significant
increase in the number of TUNEL-labeled cells in the cul-
tures exposed to BDNF (P , 0.03; data not shown).
Together, these data suggest that BDNF leads to
p75NTR activation, and that this activation causes neu-
ronal apoptosis. To directly test this hypothesis, we used
the function-blocking p75NTR antibody, REX (Weskamp
et al., 1991; Cassaccia-Bonnefil et al., 1996). Specifically,
neurons were cultured in 50 ng/ml NGF for 5 d, and then
were switched to 25 mM KCl with or without the addition
of 100 ng/ml BDNF and/or REX. 2 d later, MTT assays
were used to monitor neuronal survival. These experi-
ments (Fig. 4 A) demonstrated that REX was able to in-
hibit the BDNF-mediated apoptosis of sympathetic neu-
rons, indicating that p75NTR mediates most, if not all, of
the apoptotic effects of BDNF.
BDNF Leads to Increased Phosphorylation of c-jun
Previous work has demonstrated that increased expression
and phosphorylation of c-jun is necessary for sympathetic
neuron apoptosis caused by NGF withdrawal (Estus et al.,
1994; Ham et al., 1995). Moreover, p75NTR has been
demonstrated to activate the kinases that phosphorylate
c-jun, the jun kinase (JNK) family, in cultured oligoden-
drocytes (Casaccia-Bonnefil et al., 1996). We therefore ex-
amined c-jun in sympathetic neurons induced to undergo
apoptosis by p75NTR activation. To perform these experi-
ments, neurons were selected for 5 d in 50 ng/ml NGF, and
then were switched to 12.5 or 25 mM KCl plus or minus
BDNF. 18 h after this switch, cellular lysates were analyzed
by probing Western blots with an antibody to c-jun. As
controls, neurons were maintained in 10 ng/ml NGF, or
were withdrawn from NGF.
These experiments demonstrated that, as previously re-
ported (Ham et al., 1995), NGF withdrawal led to a shift in
c-jun to a larger size, indicative of phosphorylation (Fig.
1 E). A similar shift in c-jun size was detected in neurons
cultured in either 12.5 (Fig. 1 E) or 25 (Fig. 1 F) mM KCl
Figure 3. Sympathetic neurons undergo apoptosis in response to
BDNF. (A–D) Fluorescence photomicrographs of sympathetic
neurons analyzed by TUNEL labeling. Neurons were selected in
50 ng/ml NGF for 5 d, washed free of neurotrophin, and then
switched to 12.5 mM KCl with (D) or without (B) 100 ng/ml
BDNF for 18 h. As controls, sister cultures were maintained in 50
ng/ml NGF (A) or withdrawn from NGF (C). 18 h later, neurons
were analyzed for apoptosis using TUNEL labeling for frag-
mented nuclear DNA. (E–H) Phase-contrast photomicrographs
of cultured sympathetic neurons. Neurons were cultured as
above, and then switched to 12.5 mM KCl with (H) or without
(F) 100 ng/ml BDNF for 48 h. As controls, sister cultures were
maintained in 50 ng/ml NGF (E) or withdrawn from NGF (G).
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plus 100 or 200 ng/ml BDNF, relative to KCl alone. Thus,
BDNF induces c-jun phosphorylation in sympathetic neu-
rons coincident with neuronal apoptosis, suggesting that
one of the signal transduction pathways leading to neu-
ronal apoptosis in response to NGF withdrawal is similar
to that induced by p75NTR activation.
Sympathetic Neuron Number Is Increased and Size 
Decreased in BDNF2/2 Mice
These in vitro experiments indicate that, when neonatal
sympathetic neurons are exposed to a suboptimal survival
signal, activation of p75NTR by BDNF leads to neuronal
apoptosis. If a similar cellular mechanism occurred in vivo
during the period of naturally occurring cell death, then
one would predict that in the BDNF2/2 mice (Ernfors et al.,
1994; Jones et al., 1994), there would be an increase in the
number of sympathetic neurons. To test this prediction,
we analyzed the number of sympathetic neurons of the su-
perior cervical ganglion at postnatal day 15, immediately
after the period of target competition and cell death (Hen-
dry and Campbell, 1976; Wright et al., 1983). Specifically,
SCG from BDNF1/1 (Fig. 5 B) and 2/2 (Fig. 5 A) litter-
mates were serially sectioned at 7 mm, and the number of
neurons with an identifiable nucleolus were counted on
every third section. This analysis demonstrated a statisti-
cally significant increase of 36% in the relative number
of sympathetic neurons in BDNF2/2 mice relative to
their BDNF1/1 littermates (BDNF1/1: 15,690 6 617;
BDNF2/2: 21,318 6 1,627; P 5 0.009; n 5 6 animals each)
(Fig. 6 C; Table I).
To confirm the increase in number of sympathetic neu-
rons in the absence of BDNF, we estimated neuronal num-
ber using a second approach. Specifically, we first deter-
mined the volume of the SCG by measuring the total
cross-sectional area of every third section throughout the
entirety of individual ganglia, and then normalized for
sampling frequency and section thickness (Table I). We
then determined the mean number of neurons in a ran-
domly selected sampling volume of 214,375 mm3 from
three animals of each genotype (Table I). This latter anal-
ysis demonstrated that neuronal density was significantly
higher in the SCG of BDNF2/2 animals versus their
BDNF1/1 littermates (P , 0.0001; Table I; Fig. 5, A and
B). The volume and density measurements were then used
to estimate the total number of neurons within the SCG as
14,358 6 437 in the BDNF1/1 animals and 17,150 6 328
in the BDNF2/2 animals (Table I), a statistically signifi-
cant increase (P 5 0.003). These numbers are statistically
similar to those derived by direct counting (P . 0.05), and
support the conclusion that there are increased numbers
of sympathetic neurons in the BDNF2/2 animals.
Finally, we determined the size of sympathetic neurons
from the BDNF1/1 and BDNF2/2 animals. This mor-
phological analysis revealed a statistically significant de-
crease in sympathetic neuron cross-sectional area (Figs. 5,
A and B; and 6 A) of z1.6-fold in the absence of BDNF
(BDNF1/1: 222.24 6 6.50 mm2; BDNF2/2: 142.49 6 9.21
mm2; P 5 0.002; n 5 3 animals each), a finding that is con-
sistent with increased numbers of neurons competing for
limiting amounts of NGF. Thus, these findings indicate
that BDNF in vivo may well mediate sympathetic neuron
apoptosis, as we have documented in vitro.
Sympathetic Neuron Death Is Developmentally Delayed 
in p75NTR2/2 Mice
If, as our results from the BDNF2/2 mice suggest, ligand-
mediated activation of p75NTR is essential for naturally
occurring sympathetic neuron death, then this process
Figure 4. (A) The p75NTR antibody,
REX, inhibits the BDNF-mediated apop-
tosis of sympathetic neurons. A compari-
son of sympathetic neuron survival, as
monitored using MTT assays, in response
to 25 mM KCl 6 BDNF with and without
the presence of the function-blocking anti-
p75NTR, REX. Sympathetic neurons
were cultured in 50 ng/ml NGF for 5 d,
washed free of neurotrophin-containing
medium, and then incubated for 2 d in 25
mM KCl or 25 mM KCl 1 100 ng/ml
BDNF with or without REX. Results of
two representative experiments, each of
which was performed in triplicate, are
shown. In all cases, results represent the
mean 6 standard error, and are normal-
ized so that the survival mediated by 25
mM KCl alone is 100%. REX by itself had
no significant effect (P . 0.05) on sympa-
thetic neuron survival as mediated by 25
mM KCl. (***P , 0.004 for the comparison between 25 mM KCl 1 REX and 25 mM KCL 1 100 ng/ml BDNF 1 REX). (B) Death of
cultured p75NTR2/2 neurons is delayed after NGF withdrawal. Time course of survival of cultured p75NTR2/2 and p75NTR1/1
(Control) neurons following NGF withdrawal. Representative fields of neurons were counted immediately upon NGF withdrawal, and
again every 24 h. Results are normalized so that the number of neurons at the time of NGF withdrawal is 100%. Results represent the
mean 6 standard error of the combined data from five individual experiments each for the p75NTR2/2 and control neurons; every in-
dividual experiment was performed in triplicate. (***P , 0.002 for the comparison between p75NTR2/2 and control neurons at each
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should also be perturbed in the absence of p75NTR. To
test this prediction, we examined sympathetic neuron
numbers in the p75NTR2/2 mice during the normal pe-
riod of developmental death, which occurs during the first
few postnatal weeks in rats (Hendry and Campbell, 1976;
Hendry, 1977; Wright et al., 1983). Since the p75NTR2/2
mice analyzed in this study have been bred into a C129
background and are maintained as homozygotes, we made
two types of comparisons: an internal comparison from
birth to adulthood in the p75NTR2/2 mice, and a com-
parison of p75NTR2/2 mice with control animals of the
same C129 background.
For this analysis, we collected serial 7-mm-thick sections
of the SCG, and counted the total number of neurons con-
taining a nucleolus in every fourth section (Fig. 5, C–E).
Analysis of control C129 mice revealed that, as previously
reported in rats, naturally occurring sympathetic neuron
death in the SCG occurred between birth and P23. Sympa-
thetic neuron number at P1 was 25,328 6 927, at P4 was
23,196 6 568, at P23 was 13,415 6 1,682 (a number similar
to that observed in the BDNF1/1 animals at P15 [Table
I]), and by adulthood was 14,667 6 799 (Fig. 6, D and F;
Table I). These counts demonstrated a 42% decrease in
number of SCG neurons between birth and P23, after
which numbers remained constant (P 5 .0003, P4 versus
P23; P . 0.05, P23 versus adult; n 5 5 P1, 3 P4, 5 P23, and
5 adults). In contrast, in p75NTR2/2 mice, the neuron
number at P4 was 32,468 6 2,362, at P23 was 40,275 6
1,368, and by adulthood was 22,254 6 1,404 (Fig. 6, E and
F; Table I). Thus, in the absence of p75NTR, sympathetic
Figure 5. Morphology of
sympathetic neurons of the
superior cervical ganglion in
BDNF2/2 and p75NTR2/2
mice. Photomicrographs of
cresyl violet-stained cross-
sections of the SCG from P15
BDNF2/2 mice (A), P15
BDNF1/1 littermates (B),
P23 p75NTR2/2 mice (C),
adult C129 mice (D), and
adult p75NTR2/2 mice (E).
Bar, 38.5 mm.
Table I. Morphometric Analysis of the SCG from BDNF2/2 and p75NTR2/2 Mice
Group SCG volume
Neuron number
per 214,375 mm3
Total estimated
neuron number
Total counted
neuron number
mm3
C129 P1 0.106 6 0.008 56 6 7.2 27,698 6 3,846 25,328 6 927
C129 P4 0.121 6 0.001 40 6 0.3 22,577 6 171 23,196 6 568
C129 P23 0.120 6 0.012 32 6 2.2 17,912 6 1,355 13,415 6 1,683
C129 adult 0.121 6 0.009 30 6 1.5 16,933 6 906 14,667 6 799
p75NTR2/2 P4 0.170 6 0.021 39 6 2.9 30,927 6 2,576 32,468 6 2,362
p75NTR2/2 P23 0.202 6 0.028 44 6 6.7 41,460 6 7,197 40,275 6 1,368
p75NTR2/2 adult 0.172 6 0.005 26 6 3.9 20,860 6 3,223 22,254 6 1,404
BDNF1/1 P15 0.102 6 0.014 30 6 0.8 14,358 6 437 15,690 6 617
BDNF2/2 P15 0.083 6 0.004 44 6 0.8 17,150 6 328 21,318 6 1,627
Data are presented for the SCG from two different groups of experimental versus control animals; P15 BDNF1/1 and BDNF2/2 littermates in a BalbC/C129 background, and
p75NTR2/2 mice in a C129 background versus control C129 animals. “SCG volume” and “Neuron number per 214,375 mm3” are expressed as the mean 6 SE, and were mea-
sured as described in the Materials and Methods (n 5 3 animals for each group). The “Total estimated neuron number” is calculated as mean SCG volume 3 (mean neuron num-
ber/214,375 mm3). The “Total counted neuron number” represents the mean 6 SE of total SCG neurons determined by counting neurons with a nucleolus in every third (BDNF2/2 and
BDNF1/1) or fourth (C129 and p75NTR2/2) section, as described in the Materials and Methods. The data obtained from each individual animal is illustrated in Fig. 6. Note that
the total estimated neuron numbers and the total counted neuron numbers are statistically similar (P . 0.05 in all cases).Bamji et al. p75NTR and Neuronal Apoptosis 919
neuron number did not decrease between birth and P23, as
seen in controls, but instead increased by 24% between
birth and P23, and then decreased 45% between P23 and
adulthood (P 5 0.02, P4 versus P23; P 5 0.006, P23 versus
adult; n 5 4 P4, 5 P23, and 5 adults). This developmental
profile of sympathetic neuron number in the p75NTR2/2
mice is very similar to that observed when neonatal rats
are given NGF systemically from P6 to P21 (Hendry and
Campbell, 1976); naturally occurring sympathetic neuron
death is eliminated, and the number of sympathetic neu-
rons in the SCG increases 20% between P6 and P21, an in-
crease attributed to the rescue of sympathetic neurons that
are born postnatally (Hendry, 1977).
To obtain an independent estimate of sympathetic neu-
ron number over this developmental interval, we mea-
sured SCG volumes and neuronal density as we had for
the BDNF2/2 mice (Table I). Analysis of control C129
mice revealed that SCG volume increased from birth to
P23 and then remained relatively constant into adulthood
(Table I), as previously observed in rats (Hendry and
Campbell, 1976). In contrast, in the p75NTR2/2 mice,
SCG volume increased from P4 to P23, but then decreased
between P23 and adulthood. Moreover, p75NTR2/2
SCG volume at P23 was 1.7-fold larger than SCG volume
in the corresponding C129 animals (P , 0.05). Similar dif-
ferences were noted in neuronal density. In the control
C129 animals, neuronal density decreased from P4 to P23
(P , 0.05; Table I), and then remained constant into adult-
hood. In contrast, in the p75 NTR2/2 SCG, neuronal
density was not significantly altered between P4 and P23
(P 5 0.27), but decreased between P23 and adulthood (P ,
0.05; Table I).
The neuronal numbers estimated from the measure-
ments of ganglia volume and neuronal density confirmed
the conclusions obtained from counting neuronal profiles
(Table I). In the control C129 SCG, estimated neuron
number decreased between P4 and P23 (P 5 0.013), and
then remained constant, whereas in the p75 NTR2/2
Figure 6. At P15 to P23,
sympathetic neuron number
is increased in the SCG of
BDNF2/2 and p75NTR2/2
mice. (A) Cross-sectional
area of P15 BDNF2/2 neu-
rons relative to control neu-
rons from animals of the
same background, plotted as
a size distribution histogram,
in bins of 50 mm2. Note that
the entire population of
BDNF2/2 sympathetic neu-
rons is shifted to a smaller
size relative to BDNF1/1
(Control) neurons of the
same age. (B) Mean cross-
sectional areas of sympa-
thetic neurons of the SCG in
p75NTR2/2 mice at various
developmental time points
relative to control C129 mice.
Note that from P1 to P4, and
in adulthood, the size of sym-
pathetic neurons is similar in
the presence or absence of
p75NTR, but that at P23,
neurons lacking p75NTR are
significantly smaller. Neuron
size is expressed as cross-sectional area in mm2, and error bars represent the standard error (**P , 0.05). (C) The number of sympa-
thetic neurons of the SCG is increased in P15 BDNF2/2 animals relative to their control littermates, as determined by counting. The
number of neurons in each of six control BDNF1/1 and BDNF2/2 animals are shown; each bar represents the number of neurons in
the SCG of one animal of the indicated genotype. The means of these two groups are significantly different (***P , 0.01). The mean 6
the standard error are summarized in Table I as “Total counted neuron number.” (D) Sympathetic neuron number in the SCG of con-
trol C129 mice at developmental time points encompassing the period of naturally occurring sympathetic neuron death. The number of
neurons counted in the SCG at P1, P4, P23, and adulthood are shown; each bar represents the number of neurons in the SCG of one
C129 animal of the indicated age. Five animals were analyzed at P1, three at P4, five at P23, and five at adulthood. The mean 6 standard
error of these groups are plotted in F. (E) Sympathetic neuron number in the SCG of p75NTR2/2 mice at developmental time points
encompassing the period of naturally occurring sympathetic neuron death. The number of neurons counted in the SCG at P4, P23, and
adulthood are shown; each bar represents the number of neurons counted in the SCG of one p75NTR2/2 animal of the indicated age.
Four animals were analyzed at P4, five at P23, and five adults. The mean 6 standard error of these groups are plotted in F. (F) Compar-
ison of the time course of naturally occurring sympathetic neuron death in the SCG of p75NTR2/2 versus control (C129 control) ani-
mals. The points represent the mean 6 standard error of the counts shown in D and E. There is a highly significant decrease in neuronal
number from P4 to P23 in the control C129 mice, and from P23 to adulthood in the p75NTR2/2 mice (***P , 0.007). The means for all
of these groups are summarized in Table I as “Total counted neuron number”.The Journal of Cell Biology, Volume 140, 1998 920
SCG, estimated neuron number increased from P4 to P23,
and then decreased from P23 to adulthood (P 5 0.030; Ta-
ble I). Moreover, the absolute numbers obtained using this
estimation were statistically similar to those obtained by
direct counting (in all cases, P . 0.05; Table I). Thus, in
the absence of p75NTR, normal developmental death of
sympathetic neurons does not occur, but is instead re-
placed by a delayed period of neuronal loss between P23
and adulthood.
Since rat sympathetic neurons increase in size over this
developmental interval, we also determined neuronal size.
As reported in rats (Hendry and Campbell, 1976), neuron
size increased gradually from birth to adulthood in control
C129 animals (Figs. 5, and 6 B); the average cross-sec-
tional area at P1 to P4 was 114.86 6 6.24 mm2, at P23 was
240.73 6 16.43 mm2, and in adults was 317.06 6 26.60 mm2
(Fig. 6 B). These measurements correspond to diameters
of 12.1 mm, 17.5 mm, and 20.1 mm, respectively, numbers
very similar to those previously reported in rats (Hendry
and Campbell, 1976). Sympathetic neurons from p75NTR2/2
mice were similar in size to controls at P4 (cross-sectional
area, 121.46 6 6.44 mm2; 12.4 mm diam; P 5 0.25, n 5 3 ani-
mals each) and in adulthood (cross-sectional area, 318.72
6 5.17 mm2; 20.1 mm diam; P 5 0.47, n 5 3 animals each)
(Figs. 5, and 6 B). In contrast, at P23, p75NTR2/2 sympa-
thetic neurons were significantly smaller than their control
counterparts (cross-sectional area, 167.47 6 11.15 mm2;
14.6  mm diam; P 5 0.011, n 5 3) (Figs. 5, and 6 B), consis-
tent with increased neurons in the p75NTR2/2 mice com-
peting for limiting amounts of trophic support.
Cultured p75NTR2/2 Sympathetic Neurons Die More 
Slowly After NGF Withdrawal
The delay in sympathetic neuron death in the p75NTR2/2
mice could be due to alterations either intrinsic or extrin-
sic to the neurons themselves. To differentiate between
these two possibilities, we cultured p75NTR2/2 sympa-
thetic neurons and examined their rate of cell death after
NGF withdrawal. Specifically, sympathetic neurons of the
postnatal day 1 mouse SCG were cultured for 4 or 5 d in 50
ng/ml NGF, washed to remove the NGF, and then main-
tained in 0 or 10 ng/ml NGF-containing media for 5 d.
Fields of neurons were counted immediately upon NGF
withdrawal, and at 24-h intervals subsequent to the with-
drawal.
This analysis (Fig. 4 B) revealed p75NTR2/2 sympa-
thetic neurons died significantly more slowly than their
wild-type counterparts in the absence of NGF, indicating
that the delay in neuronal loss observed in vivo was intrin-
sic to the neurons themselves. Specifically, 48 h after NGF
withdrawal, 81.6 6 2.9% p75NTR2/2 neurons counted at
day 0 were still alive, compared to 55.6 6 4.8% of control
neurons (P , 0.005, n 5 5 each). At 72 h, 72.7 6 3.5% of
p75NTR2/2 neurons were alive versus 39.8 6 3.9% of
controls (P , 0.0001, n 5 5), whereas at 96 h, 63.9 6 5.8%
of p75NTR2/2 neurons were still alive, as opposed to
30.14  6 2.9% of controls (P , 0.005, n 5 5). By 120 h, the
last time point examined, 59.8 6 6.4% of p75NTR2/2
neurons were still alive, compared to only 19.6 6 2.3% of
control neurons (P , 0.0005, n 5 5). Moreover, at this fi-
nal time point, all of the control neurons were clearly dy-
ing, with fragmented neurites, whereas the p75NTR2/2
neurons were clearly still healthy with neurites intact.
Thus, the lack of p75NTR in sympathetic neurons them-
selves leads to a significant delay in apoptosis of these neu-
rons after NGF withdrawal, results that are consistent with
the in vivo delay in naturally occurring cell death.
Discussion
Data presented in this paper demonstrate that BDNF-
mediated activation of p75NTR is both necessary and suf-
ficient for the developmental apoptosis of sympathetic
neurons competing for limiting amounts of survival fac-
tors. Specifically, these experiments indicate that, in cul-
ture, BDNF-mediated activation of p75NTR is sufficient
to override suboptimal survival signals, whether they de-
rive from TrkA activation or chronic depolarization,
thereby leading to sympathetic neuron apoptosis. Coinci-
dent with this apoptosis, BDNF leads to phosphorylation
of the immediate early gene product, c-jun, a biochemical
event that is necessary for sympathetic neuron apoptosis
after NGF withdrawal (Estus et al., 1994; Ham et al.,
1995), presumably via activation of p75NTR signaling.
The in vivo relevance of these culture experiments is indi-
cated by two findings. First, in BDNF2/2 mice (Ernfors
et al., 1994; Jones et al., 1994), sympathetic neuron num-
ber is increased relative to BDNF1/1 littermates, an ef-
fect consistent with the lack of activation of p75NTR by
BDNF. This is the first time such an increase in neuronal
number has been reported in neurotrophin knockout
mice. Second, naturally occurring sympathetic neuron
death does not occur normally in p75NTR2/2 animals,
but there is instead delayed neuronal loss between P23
and adulthood. This delay in neuronal loss is intrinsic to
the neurons themselves, since p75NTR2/2 sympathetic
neurons display a similar delayed death in culture. Thus,
although sympathetic neuron death can occur without
p75NTR, this receptor is required for developmental apop-
tosis to occur rapidly and appropriately. 
What is the biological rationale for having two neurotro-
phin receptors, one of which, TrkA, mediates survival, and
one of which, p75NTR, mediates apoptosis? We propose
that p75NTR provides a molecular mechanism for ensur-
ing rapid and active apoptosis when a neuron is unsuccess-
ful in competing for adequate amounts of the appropriate
neurotrophin. If a sympathetic neuron reaches the appro-
priate target and sequesters NGF, TrkA is robustly acti-
vated, and any coincident activation of p75NTR is insuffi-
cient to override this survival signal. Conversely, if a
neuron is late-arriving and/or reaches an inappropriate
target, then TrkA would be only weakly induced as a con-
sequence of the lack of NGF, and p75NTR would be ro-
bustly activated by neurotrophins such as BDNF. Our data
indicate that the net outcome of such a scenario would be
the rapid apoptotic elimination of that neuron. Such a per-
turbation in the normal period of naturally occurring cell
death could at least partially explain the perturbations in
innervation observed previously in the p75NTR2/2 mice;
there is cholinergic hyperinnervation of the hippocampus
in these mice (Yeo et al., 1997), and sympathetic innerva-
tion is perturbed, with targets such as the iris being nor-
mally innervated, and targets such as the pineal glandBamji et al. p75NTR and Neuronal Apoptosis 921
completely lacking sympathetic innervation (Lee et al.,
1994). Data presented here indicate that this perturbed
sympathetic innervation is not because of a deficit in neu-
ronal number, but is instead presumably due to the failure
of p75-dependent mechanisms that are essential for
matching neurons to their target organs during the period
of naturally occurring cell death.
This model does not imply that p75NTR activation is
the only means by which sympathetic neurons die in the
absence of TrkA activation. In fact, our data demonstrat-
ing loss of sympathetic neurons between P23 and adult-
hood, and the death (albeit slow) of cultured p75NTR2/2
sympathetic neurons argue that inadequate levels of TrkA
activation do ultimately lead to the death of sympathetic
neurons even in the absence of p75NTR. Instead, we pro-
pose that p75NTR activation represents a mechanism
whereby exposure to an “inappropriate” neurotrophin is
sufficient to cause a rapid apoptotic death even in the
presence of low levels of TrkA activation. Such a mecha-
nism would ensure that neurotrophins like NT-3 and NT-4,
which weakly activate TrkA (as shown here) would not
maintain sympathetic neuron survival and circumvent the
absolute requirement for NGF, thereby leading to inap-
propriate target innervation. In fact, our data indicate that
BDNF is not the only apoptotic p75NTR ligand in vivo; af-
ter naturally occurring cell death, there are only z36%
more sympathetic neurons in the BDNF2/2 mice, but at
least twice as many in the p75NTR2/2 mice, implying
that other ligands, potentially NT-3 and/or NT-4, act
through p75NTR during developmental sympathetic neu-
ron death.
If ligand-mediated activation of p75NTR is required for
it to play an essential role in sympathetic neuron apopto-
sis, then why is there a delay in death of cultured
p75NTR2/2 versus control neurons in the absence of ex-
ogenous neurotrophins? We have previously demon-
strated (Causing et al., 1997) that BDNF is synthesized in
the rodent SCG in vivo. Moreover, cultured sympathetic
neurons synthesize BDNF, and BDNF can be detected
in media conditioned by sympathetic neurons (Causing,
C.G., R. Aloyz, and F.D. Miller, unpublished data). On
the basis of these findings, we propose that autocrine
BDNF may play a role in cultured sympathetic neuron apop-
tosis after NGF withdrawal, a hypothesis we are currently
testing. Does sympathetic neuron–derived BDNF play a
similar role in vivo? Although our data demonstrate an in-
creased number of sympathetic neurons in BDNF2/2
mice, it is unclear whether the BDNF that is critical for
this effect derives from sympathetic neurons themselves
and/or from sympathetic neuron targets. In this regard, we
have previously demonstrated that BDNF made by sym-
pathetic neurons in vivo regulates their level of pregangli-
onic input (Causing et al., 1997). One could therefore
speculate that BDNF made by sympathetic neurons might
serve both to eliminate those sympathetic neurons that did
not innervate an appropriate target (and thereby receive
adequate TrkA activation), and to ensure adequate
preganglionic input for those neurons that did successfully
compete for target territory.
The developmental profile of sympathetic neuron num-
ber observed in the absence of p75NTR is very similar to
that observed when neonates are supplied with exogenous
NGF, lending support to the notion that the absence of
p75NTR rescues sympathetic neurons from the normal pe-
riod of naturally occurring cell death. When NGF is given
systemically to rats from P6 to P21, not only are the neu-
rons that normally die rescued, but as observed in the
p75NTR2/2 mice, there is an increase of z20% in the
number of neurons (Hendry and Campbell, 1976). This in-
crease is presumably because of the fact that, during the
early period of naturally occurring cell death, sympathetic
neuroblasts continue to proliferate. However, these later-
born neurons are preferentially susceptible to programmed
cell death, and the increase in number of neurons born is
masked by the neuronal death that occurs at the same time
(Hendry, 1977). It is therefore likely that the increased num-
ber of sympathetic neurons observed at P23 in p75NTR2/2
mice is due to the same phenomenon.
What are the biochemical mechanisms that allow p75NTR
activation to override a TrkA- or KCl-mediated survival
signal? Our results demonstrate that BDNF stimulated a
hyperphosphorylation of c-jun concomitant with the ap-
pearance of apoptosis. Hyperphosphorylation of c-jun has
been previously noted in postnatal rat sympathetic neu-
rons deprived of NGF (Ham et al., 1995). Serum and NGF
withdrawal from PC12 cells also leads to sustained activa-
tion of JNK, the kinase that phosphorylates c-jun (Xia et
al., 1995). The necessity of c-jun phosphorylation in these
apoptotic responses was suggested by three types of exper-
iments; (a) expression of dominant-inhibitory c-jun in rat
sympathetic neurons protected against apoptosis caused
by NGF deprivation (Ham et al., 1995); (b) microinjection
of sympathetic neurons with antibodies to c-jun inhibited
cell death induced by NGF deprivation (Estus et al., 1995);
and (c) expression in PC12 cells of dominant-inhibitory
MEKK1 (which inhibits the activity of JNK) reduced apop-
tosis, whereas expression of activated MEKK1, which in-
directly activates JNK, increased apoptosis (Xia et al.,
1995). The observation that BDNF also stimulates c-jun
phosphorylation suggests that the MEKK1-MKK4-JNK
pathway may function in apoptosis induced by both NGF
deprivation and by activation of p75NTR. However, we do
not know whether the components of the JNK pathway
are necessary or sufficient for p75NTR-mediated cell
death. p75NTR activates several other signaling proteins,
including nuclear factor (NF)-kB and perhaps ceramide-
activated kinases, which have been hypothesized to func-
tion in the induction of apoptosis (Casaccia-Bonnefil et al.,
1996). The role of each of the p75NTR-stimulated signal-
ing proteins in apoptosis awaits experiments in which the
activities of these molecules are selectively blocked in
BDNF-treated sympathetic neurons.
p75NTR activation could also antagonize a suboptimal
TrkA survival signal by a direct action on the TrkA recep-
tor itself. Such a mechanism might involve alterations in
p75NTR–TrkA interactions to modify a high affinity sig-
naling complex (Hempstead et al., 1991; Ross et al., 1995;
Wolf et al., 1995) and/or a direct effect of p75NTR signal-
ing on the TrkA receptor involving, for example, serine/
threonine phosphorylation by ceramide-activated kinases
(MacPhee and Barker, 1997). However, our data indicate
that even if p75NTR activation directly regulates TrkA
function, there must be further downstream actions of
p75NTR that lead to apoptosis. This conclusion derivesThe Journal of Cell Biology, Volume 140, 1998 922
from our finding that BDNF-mediated activation of p75NTR
led to apoptosis in the absence of TrkA activation, when
neuronal survival was maintained by chronic depolariza-
tion. It is also likely that cross talk between the p75NTR
and TrkA is bidirectional. In this regard, Dobrowsky et al.
(1994) have demonstrated that a p75NTR-mediated cer-
amide increase was antagonized by coincident activation
of TrkA. Thus, one of the mechanisms whereby TrkA may
support neuronal survival is by silencing a neurotrophin-
mediated p75NTR death signal.
The finding of an increased number of sympathetic neu-
rons in the BDNF2/2 mice was predicted by our culture
findings, but was unexpected in light of previous studies on
this growth factor. The neurotrophins, including BDNF,
are traditionally thought to regulate neuronal survival pos-
itively via the Trk family of tyrosine kinase receptors (for
review see Snider, 1994). Here, BDNF antagonizes NGF-
or KCl-induced survival signals through the activation of
p75NTR. Such a mechanism, whereby the precise cohort
of neurotrophins to which a neuron is exposed determines
life versus death at the time of target innervation provides
a level of sophistication that was previously unsuspected.
However, this additional level of complexity provides a
mechanism whereby neurons can recognize not only
whether they are exposed to the “right” neurotrophin, but
whether or not they are seeing the “wrong” neurotrophin.
It is possible that such functional antagonism between Trk
and p75NTR provides not only a mechanism for determin-
ing neuronal survival, but also a mechanism for elimination
of axonal collaterals that innervate the inappropriate target.
Finally, although our findings indicate that p75NTR can
signal to mediate sympathetic neuron apoptosis during the
period of naturally occurring cell death, they do not imply
that p75NTR-mediated signaling inevitably results in neu-
ronal apoptosis. It is more likely that, like other members
of this family, the outcome of p75NTR-mediated signal
transduction cascades is a function of cellular context. For
example, depending upon the cellular environment,
p75NTR regulates cell migration (Anton et al., 1994), gene
expression (Itoh et al., 1995), and can positively modulate
TrkA signaling (Barker and Shooter, 1994; Verdi et al.,
1994). However, our findings indicate that during the pe-
riod of naturally occurring sympathetic neuron death, the
apoptotic actions of p75NTR are essential for the estab-
lishment of appropriate neuron–target interactions.
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